Healthcare Business Recap: Dendreon Attack Continues, Pfizer Recall

The FDA grants final approval to Perrigo’s (NASDAQ:PRGO) abbreviated new drug application for Lansoprazole capsules for the treatment of frequent reflux, and shipments to customers began immediately. In the United States, this new product is the equivalent to Novartis’ (NYSE:NVS) Prevacid 24 hour capsules.

Don’t Miss: Intuit Earnings Cheat Sheet: Profit Climbs on Smooth Quarter.

Skunk pills? More than 650,000 bottles of Pfizer’s (NYSE:PFE) Advil pain relief medicine have been voluntarily recalled, because they might possibly emit a ‘strong odor’. The recall had no involvement with safety issues.

Maxim begins coverage of Dendreon (NASDAQ:DNDN) with a Sell, as shares continue their slide of the past two days. The agnecy noted that Provenge faces logistic, manufacturing and competitive challenges that could slow sales growth.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

Investing Insights: Is Yahoo Finally Dumping Alibaba?